ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiac Biomarkers Testing Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-22Z5795
Home | Market Reports | Health| Health Conditions
Global Cardiac Biomarkers Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Cardiac Biomarkers Testing Market Research Report 2025

Code: QYRE-Auto-22Z5795
Report
August 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Becton Dickinson and Company
Biomerieux
Bio-Rad Laboratories Inc
Danaher Corporation
Roche
Siemens AG
Thermo Fisher Scientific Inc
PerkinElmer Inc
Tosoh Corporation

Cardiac Biomarkers Testing Market Size

The global market for Cardiac Biomarkers Testing was valued at US$ 8274 million in the year 2024 and is projected to reach a revised size of US$ 12780 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Cardiac Biomarkers Testing Market

Cardiac Biomarkers Testing Market

Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing.
The Cardiac Biomarkers Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiac Biomarkers Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiac Biomarkers Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cardiac Biomarkers Testing Market Report

Report Metric Details
Report Name Cardiac Biomarkers Testing Market
Accounted market size in year US$ 8274 million
Forecasted market size in 2031 US$ 12780 million
CAGR 6.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Tosoh Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cardiac Biomarkers Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cardiac Biomarkers Testing Market growing?

Ans: The Cardiac Biomarkers Testing Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Cardiac Biomarkers Testing Market size in 2031?

Ans: The Cardiac Biomarkers Testing Market size in 2031 will be US$ 12780 million.

Who are the main players in the Cardiac Biomarkers Testing Market report?

Ans: The main players in the Cardiac Biomarkers Testing Market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories, Inc., Danaher Corporation, ROCHE, Siemens AG, Thermo Fisher Scientific, Inc., PerkinElmer Inc., Tosoh Corporation

What are the Application segmentation covered in the Cardiac Biomarkers Testing Market report?

Ans: The Applications covered in the Cardiac Biomarkers Testing Market report are Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Others

What are the Type segmentation covered in the Cardiac Biomarkers Testing Market report?

Ans: The Types covered in the Cardiac Biomarkers Testing Market report are Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia-modified Albumin (IMA), Others

Recommended Reports

Cardiac Diagnostics

Biomarker Testing

Cardiovascular Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiac Biomarkers Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.3 Troponins (T and I)
1.2.4 Myoglobin
1.2.5 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.6 Ischemia-modified Albumin (IMA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiac Biomarkers Testing Market Perspective (2020-2031)
2.2 Global Cardiac Biomarkers Testing Growth Trends by Region
2.2.1 Global Cardiac Biomarkers Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cardiac Biomarkers Testing Historic Market Size by Region (2020-2025)
2.2.3 Cardiac Biomarkers Testing Forecasted Market Size by Region (2026-2031)
2.3 Cardiac Biomarkers Testing Market Dynamics
2.3.1 Cardiac Biomarkers Testing Industry Trends
2.3.2 Cardiac Biomarkers Testing Market Drivers
2.3.3 Cardiac Biomarkers Testing Market Challenges
2.3.4 Cardiac Biomarkers Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiac Biomarkers Testing Players by Revenue
3.1.1 Global Top Cardiac Biomarkers Testing Players by Revenue (2020-2025)
3.1.2 Global Cardiac Biomarkers Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cardiac Biomarkers Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cardiac Biomarkers Testing Revenue
3.4 Global Cardiac Biomarkers Testing Market Concentration Ratio
3.4.1 Global Cardiac Biomarkers Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiac Biomarkers Testing Revenue in 2024
3.5 Global Key Players of Cardiac Biomarkers Testing Head office and Area Served
3.6 Global Key Players of Cardiac Biomarkers Testing, Product and Application
3.7 Global Key Players of Cardiac Biomarkers Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiac Biomarkers Testing Breakdown Data by Type
4.1 Global Cardiac Biomarkers Testing Historic Market Size by Type (2020-2025)
4.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2026-2031)
5 Cardiac Biomarkers Testing Breakdown Data by Application
5.1 Global Cardiac Biomarkers Testing Historic Market Size by Application (2020-2025)
5.2 Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cardiac Biomarkers Testing Market Size (2020-2031)
6.2 North America Cardiac Biomarkers Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cardiac Biomarkers Testing Market Size by Country (2020-2025)
6.4 North America Cardiac Biomarkers Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiac Biomarkers Testing Market Size (2020-2031)
7.2 Europe Cardiac Biomarkers Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cardiac Biomarkers Testing Market Size by Country (2020-2025)
7.4 Europe Cardiac Biomarkers Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Biomarkers Testing Market Size (2020-2031)
8.2 Asia-Pacific Cardiac Biomarkers Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiac Biomarkers Testing Market Size (2020-2031)
9.2 Latin America Cardiac Biomarkers Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cardiac Biomarkers Testing Market Size by Country (2020-2025)
9.4 Latin America Cardiac Biomarkers Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Biomarkers Testing Market Size (2020-2031)
10.2 Middle East & Africa Cardiac Biomarkers Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cardiac Biomarkers Testing Introduction
11.1.4 Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Details
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Introduction
11.2.4 Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Cardiac Biomarkers Testing Introduction
11.3.4 BioMerieux Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.3.5 BioMerieux Recent Development
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Bio-Rad Laboratories, Inc. Company Details
11.4.2 Bio-Rad Laboratories, Inc. Business Overview
11.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Introduction
11.4.4 Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.4.5 Bio-Rad Laboratories, Inc. Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Cardiac Biomarkers Testing Introduction
11.5.4 Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.5.5 Danaher Corporation Recent Development
11.6 ROCHE
11.6.1 ROCHE Company Details
11.6.2 ROCHE Business Overview
11.6.3 ROCHE Cardiac Biomarkers Testing Introduction
11.6.4 ROCHE Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.6.5 ROCHE Recent Development
11.7 Siemens AG
11.7.1 Siemens AG Company Details
11.7.2 Siemens AG Business Overview
11.7.3 Siemens AG Cardiac Biomarkers Testing Introduction
11.7.4 Siemens AG Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.7.5 Siemens AG Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Details
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 PerkinElmer Inc.
11.9.1 PerkinElmer Inc. Company Details
11.9.2 PerkinElmer Inc. Business Overview
11.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Introduction
11.9.4 PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.9.5 PerkinElmer Inc. Recent Development
11.10 Tosoh Corporation
11.10.1 Tosoh Corporation Company Details
11.10.2 Tosoh Corporation Business Overview
11.10.3 Tosoh Corporation Cardiac Biomarkers Testing Introduction
11.10.4 Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2020-2025)
11.10.5 Tosoh Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Becton Dickinson and Company
Biomerieux
Bio-Rad Laboratories Inc
Danaher Corporation
Roche
Siemens AG
Thermo Fisher Scientific Inc
PerkinElmer Inc
Tosoh Corporation
List of Tables
 Table 1. Global Cardiac Biomarkers Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Myocardial Muscle Creatine Kinase (CK-MB)
 Table 3. Key Players of Troponins (T and I)
 Table 4. Key Players of Myoglobin
 Table 5. Key Players of Brain Natriuretic Peptide (BNPs) or NT-proBNP
 Table 6. Key Players of Ischemia-modified Albumin (IMA)
 Table 7. Key Players of Others
 Table 8. Global Cardiac Biomarkers Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Cardiac Biomarkers Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Cardiac Biomarkers Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Cardiac Biomarkers Testing Market Share by Region (2020-2025)
 Table 12. Global Cardiac Biomarkers Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Cardiac Biomarkers Testing Market Share by Region (2026-2031)
 Table 14. Cardiac Biomarkers Testing Market Trends
 Table 15. Cardiac Biomarkers Testing Market Drivers
 Table 16. Cardiac Biomarkers Testing Market Challenges
 Table 17. Cardiac Biomarkers Testing Market Restraints
 Table 18. Global Cardiac Biomarkers Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Cardiac Biomarkers Testing Market Share by Players (2020-2025)
 Table 20. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2024)
 Table 21. Ranking of Global Top Cardiac Biomarkers Testing Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Cardiac Biomarkers Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Cardiac Biomarkers Testing, Headquarters and Area Served
 Table 24. Global Key Players of Cardiac Biomarkers Testing, Product and Application
 Table 25. Global Key Players of Cardiac Biomarkers Testing, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Cardiac Biomarkers Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2020-2025)
 Table 29. Global Cardiac Biomarkers Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Cardiac Biomarkers Testing Revenue Market Share by Type (2026-2031)
 Table 31. Global Cardiac Biomarkers Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2020-2025)
 Table 33. Global Cardiac Biomarkers Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Cardiac Biomarkers Testing Revenue Market Share by Application (2026-2031)
 Table 35. North America Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Cardiac Biomarkers Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Cardiac Biomarkers Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Cardiac Biomarkers Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Cardiac Biomarkers Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Cardiac Biomarkers Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Cardiac Biomarkers Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Cardiac Biomarkers Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Cardiac Biomarkers Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Cardiac Biomarkers Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Cardiac Biomarkers Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Abbott Laboratories Company Details
 Table 51. Abbott Laboratories Business Overview
 Table 52. Abbott Laboratories Cardiac Biomarkers Testing Product
 Table 53. Abbott Laboratories Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 54. Abbott Laboratories Recent Development
 Table 55. Becton, Dickinson and Company Company Details
 Table 56. Becton, Dickinson and Company Business Overview
 Table 57. Becton, Dickinson and Company Cardiac Biomarkers Testing Product
 Table 58. Becton, Dickinson and Company Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 59. Becton, Dickinson and Company Recent Development
 Table 60. BioMerieux Company Details
 Table 61. BioMerieux Business Overview
 Table 62. BioMerieux Cardiac Biomarkers Testing Product
 Table 63. BioMerieux Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 64. BioMerieux Recent Development
 Table 65. Bio-Rad Laboratories, Inc. Company Details
 Table 66. Bio-Rad Laboratories, Inc. Business Overview
 Table 67. Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Product
 Table 68. Bio-Rad Laboratories, Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 69. Bio-Rad Laboratories, Inc. Recent Development
 Table 70. Danaher Corporation Company Details
 Table 71. Danaher Corporation Business Overview
 Table 72. Danaher Corporation Cardiac Biomarkers Testing Product
 Table 73. Danaher Corporation Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 74. Danaher Corporation Recent Development
 Table 75. ROCHE Company Details
 Table 76. ROCHE Business Overview
 Table 77. ROCHE Cardiac Biomarkers Testing Product
 Table 78. ROCHE Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 79. ROCHE Recent Development
 Table 80. Siemens AG Company Details
 Table 81. Siemens AG Business Overview
 Table 82. Siemens AG Cardiac Biomarkers Testing Product
 Table 83. Siemens AG Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 84. Siemens AG Recent Development
 Table 85. Thermo Fisher Scientific, Inc. Company Details
 Table 86. Thermo Fisher Scientific, Inc. Business Overview
 Table 87. Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Product
 Table 88. Thermo Fisher Scientific, Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 89. Thermo Fisher Scientific, Inc. Recent Development
 Table 90. PerkinElmer Inc. Company Details
 Table 91. PerkinElmer Inc. Business Overview
 Table 92. PerkinElmer Inc. Cardiac Biomarkers Testing Product
 Table 93. PerkinElmer Inc. Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 94. PerkinElmer Inc. Recent Development
 Table 95. Tosoh Corporation Company Details
 Table 96. Tosoh Corporation Business Overview
 Table 97. Tosoh Corporation Cardiac Biomarkers Testing Product
 Table 98. Tosoh Corporation Revenue in Cardiac Biomarkers Testing Business (2020-2025) & (US$ Million)
 Table 99. Tosoh Corporation Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Cardiac Biomarkers Testing Picture
 Figure 2. Global Cardiac Biomarkers Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiac Biomarkers Testing Market Share by Type: 2024 VS 2031
 Figure 4. Myocardial Muscle Creatine Kinase (CK-MB) Features
 Figure 5. Troponins (T and I) Features
 Figure 6. Myoglobin Features
 Figure 7. Brain Natriuretic Peptide (BNPs) or NT-proBNP Features
 Figure 8. Ischemia-modified Albumin (IMA) Features
 Figure 9. Others Features
 Figure 10. Global Cardiac Biomarkers Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Cardiac Biomarkers Testing Market Share by Application: 2024 VS 2031
 Figure 12. Myocardial Infarction Case Studies
 Figure 13. Congestive Heart Failure Case Studies
 Figure 14. Acute Coronary Syndrome Case Studies
 Figure 15. Atherosclerosis Case Studies
 Figure 16. Others Case Studies
 Figure 17. Cardiac Biomarkers Testing Report Years Considered
 Figure 18. Global Cardiac Biomarkers Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Cardiac Biomarkers Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Cardiac Biomarkers Testing Market Share by Region: 2024 VS 2031
 Figure 21. Global Cardiac Biomarkers Testing Market Share by Players in 2024
 Figure 22. Global Top Cardiac Biomarkers Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Biomarkers Testing as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Cardiac Biomarkers Testing Revenue in 2024
 Figure 24. North America Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Cardiac Biomarkers Testing Market Share by Country (2020-2031)
 Figure 26. United States Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Cardiac Biomarkers Testing Market Share by Country (2020-2031)
 Figure 30. Germany Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Cardiac Biomarkers Testing Market Share by Region (2020-2031)
 Figure 38. China Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Cardiac Biomarkers Testing Market Share by Country (2020-2031)
 Figure 46. Mexico Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Cardiac Biomarkers Testing Market Share by Country (2020-2031)
 Figure 50. Turkey Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Cardiac Biomarkers Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Abbott Laboratories Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 54. Becton, Dickinson and Company Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 55. BioMerieux Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 56. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 57. Danaher Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 58. ROCHE Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 59. Siemens AG Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 61. PerkinElmer Inc. Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 62. Tosoh Corporation Revenue Growth Rate in Cardiac Biomarkers Testing Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

LFA based Cardiac Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Biomarkers Testing Device Market Research Report 2025
Global Clinical Biomarker Testing Market Research Report 2024
Global Commercializing Biomarkers Market Research Report 2025
Global Diagnostic Biomarker Market Research Report 2024
Global Brain Biomarker Market Research Report 2024
Global Central Nervous System Biomarkers Market Insights Forecast to 2030
Global Cardiac Marker Analyzer Market Research Report 2025
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antibodies and Antigens to Cardiovascular Biomarkers Market Research Report 2025
Global Cholesterol Testing Products and Services Market Insights Forecast to 2030
Global Oncology Biomarker Market Insights Forecast to 2030
Global Digital Biomarker Market Research Report 2025
Global Targeted Biomarker Market Insights Forecast to 2030
Global Cardiac Biomarker Diagnostic Kits Market Research Report 2025
Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Cardiac Marker Analyzer Market Research Report 2024
Stroke Testing Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Myoglobin Test Market Insights Forecast to 2030

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Bladder Cancer Therapeutics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38Z13489
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Allergy Skin Test Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12K7064
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Urinary Slings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26L5971
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions